SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-100115
Filing Date
2023-09-13
Accepted
2023-09-12 18:01:32
Documents
13
Period of Report
2023-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325985d1_8k.htm   iXBRL 8-K 29474
2 EXHIBIT 10.1 tm2325985d1_ex10-1.htm EX-10.1 150694
  Complete submission text file 0001104659-23-100115.txt   385886

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20230906.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20230906_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20230906_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2325985d1_8k_htm.xml XML 3299
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 231251180
SIC: 3841 Surgical & Medical Instruments & Apparatus